Filed 8mo ago· Sep 12, 2025
21 days to disclose
John Boozman
RSenateArkansas
↓sold
AbbVie
ABBV
$1K-$15K
+7.5% vs S&P 500
Trade dateAug 22, 2025
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.













| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Sep 12, 2025 8mo ago | ![]() John Boozman RSenateArkansas | ↓sold | AbbVie ABBV | Aug 22, 2025 21 days to disclose | Flat·+0.0% +7.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() John Boozman RSenateArkansas | ↓sold | AbbVie ABBV | Aug 11, 2025 32 days to disclose | Flat·+0.0% +14.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2024 2.1y ago | ![]() Tommy Tuberville RSenateAlabama | ↑bought | AbbVie ABBV Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2024 42 days to disclose | Good buy·+$965+12.1% −25.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2024 2.3y ago | ![]() Tommy Tuberville RSenateAlabama | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 19, 2024 26 days to disclose | Flat·+0.0% +6.5% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2023 2.5y ago | ![]() Tommy Tuberville RSenateAlabama | ↓sold | AbbVie ABBV Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Nov 20, 2023 25 days to disclose | Flat·+0.0% +61.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2023 2.5y ago | ![]() Tommy Tuberville RSenateAlabama | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 17, 2023 30 days to disclose | Good buy·+$2.7K+33.2% −30.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2023 3.1y ago | ![]() Tommy Tuberville RSenateAlabama | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2023 39 days to disclose | Flat·+0.0% +13.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 11, 2023 3.1y ago | ![]() Tommy Tuberville RSenateAlabama | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2023 38 days to disclose | Flat·+0.0% +13.4% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 8, 2022 4.2y ago | ![]() Tommy Tuberville RSenateAlabama | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Mar 30, 2022 9 days to disclose | Good buy·+$1.7K+21.3% −34.3% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2022 4.3y ago | ![]() Tommy Tuberville RSenateAlabama | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 21, 2022 24 days to disclose | Missed gain·−$4K-50.6% +12.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 3, 2022 4.3y ago | ![]() Thomas R Carper DSenateDelaware | ↓sold | AbbVie ABBV | Jan 18, 2022 16 days to disclose | Missed gain·−$3.6K-45.3% +11.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 17, 2021 5.0y ago | ![]() Thomas R Carper DSenateDelaware | ↑bought | AbbVie ABBV | Nov 20, 2020 178 days to disclose · 133 past 45-day window | price pending | $1K-$15K midpoint $8K |
May 17, 2021 5.0y ago | ![]() Thomas R Carper DSenateDelaware | ↓sold | AbbVie ABBV | Jul 9, 2020 312 days to disclose · 267 past 45-day window | price pending | $1K-$15K midpoint $8K |
May 2, 2021 5.1y ago | DJ David A Perdue , Jr —Senate | ↓sold | AbbVie ABBV | Apr 14, 2020 383 days to disclose · 338 past 45-day window | price pending | $15K-$50K midpoint $32.5K |